References

1: Conrad S, Weber K, Walliser U, Geburek F, Skutella T. Stem Cell Therapy for Tendon Regeneration: Current Status and Future Directions. Adv Exp Med Biol. 2018 Jul 25. doi: 10.1007/5584_2018_194. [Epub ahead of print] PubMed PMID: 30043235.

2: Geburek F, Roggel F, van Schie HTM, Beineke A, Estrada R, Weber K, Hellige M, Rohn K, Jagodzinski M, Welke B, Hurschler C, Conrad S, Skutella T, van de Lest C, van Weeren R, Stadler PM. Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial. Stem Cell Res Ther. 2017 Jun 5;8(1):129. doi: 10.1186/s13287-017-0564-8. PubMed PMID: 28583184; PubMed Central PMCID: PMC5460527.

3: Geburek F, Mundle K, Conrad S, Hellige M, Walliser U, van Schie HT, van Weeren R, Skutella T, Stadler PM. Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions--a pilot study. Stem Cell Res Ther. 2016 Feb 1;7:21. doi: 10.1186/s13287-016-0281-8. PubMed PMID: 26830812; PubMed Central PMCID: PMC4736260.

4: Conze P, van Schie HT, van Weeren R, Staszyk C, Conrad S, Skutella T, Hopster K, Rohn K, Stadler P, Geburek F. Effect of autologous adipose tissue-derived mesenchymal stem cells on neovascularization of artificial equine tendon lesions. Regen Med. 2014;9(6):743-57. doi: 10.2217/rme.14.55. PubMed PMID: 25431911.